Piperlongumine exerts cytotoxic effects against cancer cells with mutant p53 proteins at least in part by restoring the biological functions of the tumor suppressor

被引:36
作者
Basak, Debasish
Punganuru, Surendra R.
Srivenugopal, Kalkunte S. [1 ]
机构
[1] Texas Tech Univ, Sch Pharm, Dept Biomed Sci, Hlth Sci Ctr, 1406 S Coulter Dr, Amarillo, TX 79106 USA
关键词
reactivation of mutant p53; oxidative stress; cancer chemotherapy; protein glutathionylation; drug resistance; MOLECULAR-WEIGHT COMPOUND; DNA-BINDING DOMAIN; OXIDATIVE STRESS; TARGETING P53; GLUTATHIONYLATION; REACTIVATION; MECHANISMS; ANTIBODIES; CYSTEINES; APOPTOSIS;
D O I
10.3892/ijo.2016.3372
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Piperlongumine (PL), a small molecule alkaloid present in black pepper (Piper longum), has been reported to kill tumor cells irrespective of their p53 gene status, however, the mechanisms involved are unknown. Since p53 is a redox-sensitive protein, we hypothesized that the redox imbalance induced by PL may affect the structure and/or function of the mutant p53 protein and promote cell death. We used two human colon cancer cell lines, the HT29 and SW620 which harbor the R273H DNA contact abrogatory mutation in p53. PL treatment induced significant ROS production and protein glutathionylation with a concomitant increase in Nrf-2 expression in both cell lines. Surprisingly, immunoprecipitation with wt-p53 specific antibodies (PAb1620) or direct western blotting showed a progressive generation of wild-type-like p53 protein along with a loss of its mutant counterpart in PL-treated HT29 and SW620 cells. Moreover, the EMSA and DNA-affinity blotting revealed a time-dependent restoration of DNA-binding for the mutant p53, which was accompanied by the induction of p53 target genes, MDM2 and Bax. PL, while cytotoxic by itself, also increased the cell killing by many anticancer drugs. In nude mice bearing the HT29 tumors, PL alone (7.5 mg/kg daily) produced a 40% decrease in tumor volume, which was accompanied by diminished intratumoral mutant p53 protein levels. The antitumor efficacy of BCNU or doxorubicin in HT29 xenografts was highly potentiated by PL, followed by expression of apoptotic proteins. These clinically-relevant findings suggest that PL-induced oxidative milieu facilitates a weak functional restoration of mutant p53 through protein glutathionylation and contributes to the increased drug sensitivity.
引用
收藏
页码:1426 / 1436
页数:11
相关论文
共 37 条
  • [1] Synthesis, cellular evaluation, and mechanism of action of piperlongumine analogs
    Adams, Drew J.
    Dai, Mingji
    Pellegrino, Giovanni
    Wagner, Bridget K.
    Stern, Andrew M.
    Shamji, Alykhan F.
    Schreiber, Stuart L.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (38) : 15115 - 15120
  • [2] Nrf2 in health and disease: current and future clinical implications
    Al-Sawaf, Othman
    Clarner, Tim
    Fragoulis, Athanassios
    Kan, Yuet Wai
    Pufe, Thomas
    Streetz, Konrad
    Wruck, Christoph Jan
    [J]. CLINICAL SCIENCE, 2015, 129 (12) : 989 - 999
  • [3] The relationship between Bcl2, Bax and p53: consequences for cell cycle progression and cell death
    Basu, A
    Haldar, S
    [J]. MOLECULAR HUMAN REPRODUCTION, 1998, 4 (12) : 1099 - 1109
  • [4] Bonsing BA, 1997, CYTOMETRY, V28, P11, DOI 10.1002/(SICI)1097-0320(19970501)28:1<11::AID-CYTO2>3.3.CO
  • [5] 2-H
  • [6] SYNTHESIS OF DIACETYLDICHLOROFLUORESCIN - A STABLE REAGENT FOR FLUOROMETRIC ANALYSIS
    BRANDT, R
    KESTON, AS
    [J]. ANALYTICAL BIOCHEMISTRY, 1965, 11 (01) : 6 - &
  • [7] Reactivation of mutant p53 and induction of apoptosis in human tumor cells by maleimide analogs
    Bykov, VJN
    Issaeva, N
    Zache, N
    Shilov, A
    Hultcrantz, M
    Bergman, J
    Selivanova, G
    Wiman, KG
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (34) : 30384 - 30391
  • [8] Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound
    Bykov, VJN
    Issaeva, N
    Shilov, A
    Hultcrantz, M
    Pugacheva, E
    Chumakov, P
    Bergman, J
    Wiman, KG
    Selivanova, G
    [J]. NATURE MEDICINE, 2002, 8 (03) : 282 - 288
  • [9] Mutant p53 reactivation by small molecules makes its way to the clinic
    Bykov, Vladimir J. N.
    Wiman, Klas G.
    [J]. FEBS LETTERS, 2014, 588 (16): : 2622 - 2627
  • [10] Mutant p53 rescue and modulation of p53 redox state
    Bykov, Vladimir J. N.
    Lambert, Jeremy M. R.
    Hainaut, Pierre
    Wiman, Klas G.
    [J]. CELL CYCLE, 2009, 8 (16) : 2509 - 2517